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We are grateful to our many colleagues who took the time to respond to our analysis of Shanghai’s declining “avoidable mortality.”1 The range of their 
perspectives across 5 recent commentaries reassures us that 
the topic is worthy of sustained study. Indeed, the presumption 
behind our comparative research on healthcare in world cities2 
is that the city is a strategic unit of analysis for understanding 
the health sector and that world cities share a host of important 
characteristics. Contrary to Cheng’s3 comment that we 
compared “disparate cities whose only common characteristic 
is that they are of mega-size,” we have relied on a “most similar 
systems” approach to comparative analysis.4 World cities are 
characterized by high population size and density, similar 
commuting patterns between their outer rings and urban 
cores, and similar functions in the realms of international 
finance, culture, media, and provision of tertiary and 
quaternary medical care. Likewise, they exhibit flagrant socio-
economic inequalities, share many of the same strengths and 
weaknesses, but exist within nations with strikingly different 
health policies. Thus, comparisons among these cities, as well 
as within them (across neighborhoods), can shed light on the 
implications of national health policy for access to care, as well 
as on the importance of urban health policies for grappling 
with local health challenges.
We agree with Ren’s comment5 that it would have been 
preferable to compare our data from New York City, Paris 
(and first ring) and Greater London to Shanghai City with 
a population of 10 million. Indeed, we attempted to do so, 
but the Shanghai Municipal Center for Disease Control and 
Prevention (SCDC) provided disaggregated mortality data, by 
cause, only for all of Shanghai. This problem reflects a broader 
issue in comparative urban health services research. While 
international comparisons are typically conducted across 
nation states with data assembled by leading international 
organizations (UN, OECD, WHO), there is no international 
association of large cities that provides comparable data 
for urban areas, their central cores, outer rings, let alone 
neighborhoods within them. This problem is well illustrated in 
the commentary by Yip and Chen6 where they present 2 graphs 
comparing life expectancy at birth across 6 cities. London, 
New York City and Hong Kong are comparable in terms of 
population size, but once again Shanghai probably refers to the 
whole city, Tokyo probably reflects the entire Prefecture that 
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extends way beyond the most heavily urbanized areas, and 
Paris (if they did not include the first ring) includes only the 
2.1 million population living in the dense and historic urban 
core. 
The problem of inadequate data at the city-level is also the 
reason why Yip and Chen’s6 suggestion that we assess health-
adjusted life expectancy (HALE) and disability adjusted life 
years (DALY) for Shanghai is not practical. Putting aside 
the considerable ethical problems raised by how to weight 
different states of health, even in New York City for which we 
have a great deal of information about population health at 
the local level, we do not have sufficient data on prevalence 
of disease necessary to calculate such measures. Surely, as the 
world becomes increasingly urban, the demand for databases 
across world cities, as well as smaller ones, will increase and 
make it possible to deepen the kinds of research we began 
more than a decade ago.7,8 
There is a final issue provoked by the indicator on which we 
based our analysis – amenable mortality (AM). We propose 
to address this issue in more detail because three of the 
commentaries raised it in different ways. Yan and Zhang9 
note the “unavoidable limitations of the concept of AM.” They 
state – correctly in our judgment – that “it might be disputable 
to jump to the conclusion that: ‘investments in public health 
infrastructure and increasing access to health services in 
megacities – both in China and worldwide – can produce 
significant mortality declines.’” Likewise, Cheng3 notes that 
our hypothesis is “data compatible… and plausible” but that 
we “cannot rule out alternative, plausible hypotheses on other 
factors that may have driven the decline in AM in Shanghai.” 
Finally, Yip and Chen6 criticize us for not producing empirical 
data to “demonstrate a direct link for (the) causal relationship” 
between the decline in AM and improvement in Shanghai’s 
healthcare system. In fact, we do provide some evidence of 
substantial investments in the healthcare system and Fabre’s10 
commentary highlights the emerging role of healthcare 
investments as part of China’s new growth regime.
We are surprised by these reactions because they misconstrue 
the purpose of our analysis. We did not seek to validate the 
AM indicator. There is an extensive literature on this score 
including a recent analysis by Heijink and colleagues11 that 
finds a statistically significant relationship between healthcare 
spending and AM. All indicators are subject to limitations 
and caveats that must be examined before making claims 
about causality. Indeed, that is why they are called “indicators.” 
We relied on the indicator, AM, because there is strong 
evidence in the literature we cited that this indicator tells 
us something important about one dimension of healthcare 
system performance. To suggest, as our critics have, that there 
are other important factors, aside from access to effective 
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healthcare, that have contributed to health improvements 
in Shanghai is indisputable. To imply that we should have 
disentangled the relative importance of these factors in the 
case of Shanghai simply because we relied on the AM indicator 
is unreasonable. It is, as if we relied on life expectancy at 
birth or infant mortality to compare levels of well-being 
and were told that there are many other factors to consider 
before making causal claims! For all those who recognize the 
overwhelming importance of social determinants of health 
(SDH) in explaining population health status, we share your 
view. But for those who refuse to recognize that the AM 
indicator has something to add in assessing an important 
dimension of healthcare system performance, we recommend 
that you read Allin and Grignon’s12 incisive defense of the 
indicator.
Needless to say, we recognize that the use of comparative 
rates of AM to estimate gains in health from improved health 
system performance is limited by lack of available data to 
assess more directly health system performance (eg, hospital 
readmission rates or admission rates for ambulatory care 
sensitive conditions or use of recommended primary and 
secondary clinical and preventive services. Similarly, without 
the collection of small-area socio-demographic measures, the 
influence of such factors as poverty cannot be determined. 
In our comparisons of world cities2, we have emphasized the 
extent to which New York City reflects national policy in the 
United States of not sufficiently (in our judgment) reducing 
inequities in the SDH, but also because the United States – even 
after passage of the Affordable Care Act (ACA) – has not come 
close to eliminating financial barriers in access to healthcare. 
Most other studies of these problems either emphasize the 
decisive impact of SDH or the importance of healthcare 
access. We have chosen a middle ground in which we pay 
attention to the consequences of poor social conditions, as 
well as access barriers to healthcare services that can prevent 
disease, improve health, reduce avoidable hospitalizations, 
and ultimately reduce premature mortality amenable to 
healthcare.13 It is for these reasons that we rely on the AM 
indicator, among others, to provide preliminary assessments 
of urban healthcare systems.
Our purpose in collaborating with colleagues in Shanghai 
was to show how analysis of available data on one important 
indicator of healthcare system performance can be used to 
provide a comparative perspective on achievements to date 
and to stimulate discussion of next steps in promoting useful 
research on how Shanghai’s healthcare system can continue to 
improve. At the end of the day, we are convinced that it is not 
sufficient simply to state that health reforms have improved 
the healthcare system.14 Saying so does not make it so! Also, 
as we note in our paper and as all of the commentaries have 
reiterated, without data on the health status of Shanghai’s 
migrant population, it is impossible to make legitimate claims 
about Shanghai’s population health and its healthcare system. 
Finally, it will be important to conduct neighborhood-
level analyses of population health and access to healthcare 
services to advance our capacity to assess the performance 
of Shanghai’s healthcare system and make more meaningful 
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